Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency¹)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Insulet Corporation (PODD) PT Raised to $280 at Stifel
August 5, 2022 11:53 AM EDTStifel analyst Matthew Blackman raised the price target on Insulet Corporation (NASDAQ: PODD) to $280.00 (from $250.00) while maintaining a Hold rating following earnings.
The analyst commented, "The most important takeaway from PODD's 2Q22 was the solid US performance, led by Omnipod 5. Strong demand, from... More
Insulet (PODD) Q2 Revenue Beats
August 4, 2022 4:39 PM EDTInsulet (NASDAQ: PODD) reported Q2 EPS of ($0.50), which may not compare to the analyst estimate of $0.22. Revenue for the quarter came in at $299.4 million versus the consensus estimate of $291.45 million.
GUIDANCE:
For the year ending December 31, 2022, the Company is raising its... More
